Drug Profile


Alternative Names: Cicaprost clathrate; ZK 96480; ZK 97959

Latest Information Update: 25 Sep 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer Schering Pharma
  • Developer Bayer HealthCare Pharmaceuticals; Bayer Schering Pharma
  • Class Antiplatelets; Prostaglandins; Small molecules
  • Mechanism of Action Epoprostenol agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer metastases
  • Discontinued Ischaemic heart disorders; Thrombosis

Most Recent Events

  • 25 Sep 2000 No-Development-Reported for Cancer metastases in USA (Unknown route)
  • 02 Oct 1997 Discontinued-II for Ischaemic heart disorders in Germany (PO)
  • 02 Oct 1997 Discontinued-II for Thrombosis in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top